Nurse Practitioner, Primary Care · Boston, MA
NPI
1972957637
Since 2016
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1340 Boylston St
Boston, MA, 02215
Phone (617) 247-7555
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$314K
501 prescriptions
Company payments, 2023
$330
From 9 companies
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Kahn prescribed most often to Medicare patients was Rosuvastatin Calcium, with 30 prescriptions and refills. In total Daniel Kahn wrote 501 Medicare prescriptions that cost $314K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-09-17.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Rosuvastatin Calcium Generic | 30 | 54 | Under 11 | $426 |
| Lisinopril Generic | 25 | 52 | Under 11 | $239 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 23 | 23 | Under 11 | $89K |
| Atorvastatin Calcium Generic | 21 | 60 | Under 11 | $167 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 18 | 18 | Under 11 | $61K |
| Valacyclovir Valacyclovir Hcl | 16 | 18 | Under 11 | $444 |
| Bupropion Xl Bupropion Hcl | 16 | 24 | Under 11 | $232 |
| Doxycycline Hyclate Generic | 15 | 15 | 15 | $187 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 14 | 14 | Under 11 | $501 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 13 | 31 | Under 11 | $34K |
| Tamsulosin Hcl Generic | 11 | 29 | Under 11 | $149 |
| Omeprazole Generic | 11 | 27 | Under 11 | $183 |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | 11 | 11 | Under 11 | $52K |
| Testosterone Cypionate Generic | 11 | 11 | Under 11 | $207 |
| Gabapentin Generic | 11 | 11 | Under 11 | $55.82 |
Brand drugs: 97 claims; generic drugs: 404 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Daniel Kahn $330 ($330 in general payments such as food, travel and fees) from 9 companies. The largest payer was Novo Nordisk Inc with $82.73.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 5 | $82.73 |
| Idorsia Pharmaceuticals US Inc | 3 | $63.78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $34.45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $33.46 |
| Tolmar, Inc. | 2 | $29.94 |
| Abbvie Inc. ABBV | 1 | $28.69 |
| GlaxoSmithKline, LLC. GSK | 1 | $21 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $20.57 |
| Merck Sharp & Dohme LLC MRK | 1 | $15.55 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.